Immunotherapy Advances for Epithelial Ovarian Cancer

SIMPLE SUMMARY: The overall five-year survival rate in epithelial ovarian cancer is 44% and has only marginally improved in the past two decades. Despite an initial response to standard treatment consisting of chemotherapy and surgical removal of tumor, the lesions invariably recur, and patients ult...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartnett, Erin G., Knight, Julia, Radolec, Mackenzy, Buckanovich, Ronald J., Edwards, Robert P., Vlad, Anda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764119/
https://www.ncbi.nlm.nih.gov/pubmed/33322601
http://dx.doi.org/10.3390/cancers12123733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764119/
https://www.ncbi.nlm.nih.gov/pubmed/33322601
http://dx.doi.org/10.3390/cancers12123733

Ejemplares similares